1. Inicio
  2. Publicaciones
  3. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.

Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.

Fecha de publicación: Fecha Ahead of Print:

Autores de I3PT

Participantes ajenos a I3PT

  • Cueva JF
  • Palacio I
  • Churruca C
  • Herrero A
  • Pardo B
  • Constenla M
  • Santaballa A
  • Manso L
  • Estévez P
  • Maximiano C
  • Legerén M
  • Marquina G
  • de Juan A
  • Quindós M
  • Sánchez L
  • Barquin A
  • Fernández I
  • Martín C
  • Juárez A
  • Martín T
  • Yubero A
  • Gallego A
  • Martínez Bueno A
  • Guerra E
  • González-Martín A

Grupos de Investigación

Abstract

To describe patient characteristics, effectiveness and safety in a real-world population treated with niraparib in the Spanish expanded-access programme.

Datos de la publicación

ISSN/ISSNe:
0959-8049, 1879-0852

EUROPEAN JOURNAL OF CANCER  ELSEVIER SCI LTD

Tipo:
Article
Páginas:
3-14
PubMed:
36706655
Enlace a otro recurso:
www.scopus.com

Citas Recibidas en Web of Science: 12

Citas Recibidas en Scopus: 1

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Elderly, Individualised, Niraparib, PARP inhibitor, Platinum-sensitive, Real-world data, Recurrent ovarian cancer

Campos de Estudio

Compartir